11682 EL CAMINO REAL, SUITE 120, SAN DIEGO, CA
Reports First Quarter 2026 Financial Results and Corporate Update
Donn Casale Appointed President of ARS Pharmaceuticals, Inc.
Annual Report to Security Holders
Investor Presentation
Reports Third Quarter 2025 Financial Results and Highlights for neffy® (epinephrine nasal spray)
News, Material Contracts
Other Events
Reports Second Quarter 2025 Financial Results and Highlights Accelerating Growth for neffy® (epinephrine nasal spray)
Q1
FY 2025
Q3
Q2
FY 2024
Q3 amended
Registration Statement for Securities to be Offered to Employees
S-3ASR
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Additional Proxy Materials
Definitive Proxy Statement
Amended Schedule 13G - Ownership Report
Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Amended Schedule 13D - Ownership Report
Submission Upload
Correspondence